ClinicalTrials.Veeva

Menu

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

R

Rambam Health Care Campus

Status

Unknown

Conditions

Non-Small Cell Lung Carcinoma
Venous Thromboembolism

Treatments

Procedure: Blood sample withdrawal

Study type

Observational

Funder types

Other

Identifiers

NCT00192829
Thrombosis and cancer.CTIL

Details and patient eligibility

About

The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possible value of hypercoagulable parameters as prognostic parameters in advanced non-small cell lung carcinoma (NSCLC).

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically or cytologically confirmed diagnosis of NSCLC.
  • normal serum bilirubin
  • informed concent to participate in the study

Exclusion criteria

  • anticoagulant therapy
  • infectious disease

Trial contacts and locations

2

Loading...

Central trial contact

Galit Sarig, Ph.D; Nissim Haim, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems